FZD3 and hepatocellular carcinoma: Nonetheless, additional experiments will be required to assess the impact of the different WNT3/4/5A and FZD3/6/7 combinations for activation of the FZD-dependent pathways and control of the cancerous phenotype in a specific context-dependent cell state (HCC cells, nontransformed progenitors, and primary cells).